ARCH Venture Fund XIII L.P. insider trades
Open-market stock purchases and sales by ARCH Venture Fund XIII L.P., 10% Owner at Lyell Immunopharma, Inc, from SEC Form 4 filings since Mar 6, 2026.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -53%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 6, 2026 | LYEL Lyell Immunopharma, Inc | Bought | $12.5M |
Companies traded
- LYEL Lyell Immunopharma, Inc: 1 buy, last Mar 6, 2026
Get free alerts when ARCH Venture Fund XIII L.P. files a new trade →